These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1625405)

  • 41. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
    Anastasatu C; Bercea O; Barcan F; Stinghe R; Dinulică E; Marcovici M; Cristea M; Cărpinişan L; Gheorghiu M; Iancovici O; Ghinescu S
    Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931
    [No Abstract]   [Full Text] [Related]  

  • 42. Daily short course (6 months) chemotherapy for treatment of pulmonary tuberculosis in Nigerians: a preliminary report.
    Onadeko BO; Sofowora EO
    Afr J Med Med Sci; 1978 Sep; 7(3):175-81. PubMed ID: 108938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum drug concentrations of INH and RMP predict 2-month sputum culture results in tuberculosis patients.
    Mah A; Kharrat H; Ahmed R; Gao Z; Der E; Hansen E; Long R; Kunimoto D; Cooper R
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):210-5. PubMed ID: 25574921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion.
    Sundaram V; Fujiwara PI; Driver CR; Osahan SS; Munsiff SS
    Int J Tuberc Lung Dis; 2002 Mar; 6(3):238-45. PubMed ID: 11934142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
    Toyota E; Suzuki T; Tagawa K; Takahara M; Ito M; Arai T; Kabe J; Baba H
    Kekkaku; 1994 Sep; 69(9):559-63. PubMed ID: 7967317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
    Tuber Lung Dis; 1992 Feb; 73(1):59-67. PubMed ID: 1326349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Improved technology of chemotherapy of pulmonary tuberculosis complicated by other diseases].
    Gavril'ev SS; Nikolaev VP; Vinokurova MK; Petukhova NIu; Gavril'eva LP; Malogulova ISh
    Probl Tuberk; 2001; (2):8-11. PubMed ID: 11490482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Investigation on bacteriological relapses in cases of pulmonary tuberculosis treated with INH and RFP--report of the 27th B series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Mochizuki K; Shigeto E; Kobayashi Y; Nagasawa S
    Kekkaku; 1987 May; 62(5):265-80. PubMed ID: 3626256
    [No Abstract]   [Full Text] [Related]  

  • 49. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
    Iukhimenko NV
    Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-course chemotherapy for pulmonary tuberculosis.
    Fox W; Mitchison DA
    Am Rev Respir Dis; 1975 Mar; 111(3):325-53. PubMed ID: 47233
    [No Abstract]   [Full Text] [Related]  

  • 51. [Standardized controlled antitubercular therapy and results in 755 patients].
    Wiesner B; Cramer G; Hamel U; Roth G
    Z Erkr Atmungsorgane; 1991; 177(1-2):71-5. PubMed ID: 1808855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
    Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinico-radiological results in 42 patients with pulmonary tuberculosis treated with Rifampicin].
    Lijoi N; Bolondi O; Franzini Costi T; Mosti A; Ortaggio F
    Arch Monaldi; 1970; 25(3):201-34. PubMed ID: 5510348
    [No Abstract]   [Full Text] [Related]  

  • 55. [Survey of the initial treatment of pulmonary tuberculosis in West Germany. A study by the German Central Committee for the Prevention of Tuberculosis].
    Zierski M; Hoffmann O; Bornhardt E
    Pneumologie; 1989 Dec; 43(12):691-702. PubMed ID: 2622876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.
    Dutt AK; Moers D; Stead WW
    Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1232-5. PubMed ID: 2111106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The present situation, treatment and prognosis of drug-resistant pulmonary tuberculosis. Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanitoria in Japan].
    Sato K; Nagai H; Kurashima A; Mori M; Katayama T
    Kekkaku; 1995 Oct; 70(10):585-9. PubMed ID: 8523851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
    Dorman SE; Johnson JL; Goldberg S; Muzanye G; Padayatchi N; Bozeman L; Heilig CM; Bernardo J; Choudhri S; Grosset JH; Guy E; Guyadeen P; Leus MC; Maltas G; Menzies D; Nuermberger EL; Villarino M; Vernon A; Chaisson RE;
    Am J Respir Crit Care Med; 2009 Aug; 180(3):273-80. PubMed ID: 19406981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.